Uganda's pharmaceutical distribution network spans from large wholesalers in Kampala to regional depots and over 14,000 licensed drug outlets nationwide. Maintaining this complex supply chain while ensuring product quality, managing expiry dates, and preventing counterfeit entry requires robust systems and NDA compliance.
Key challenges
Counterfeit medicines remain a persistent threat despite NDA enforcement operations. Cold chain gaps — limited temperature-controlled storage and transport — risk product integrity. Last-mile delivery to rural health facilities is complicated by poor road infrastructure and high transport costs. Stockouts and expiry due to poor inventory management affect both public and private facilities.
Regulatory requirements
A valid NDA wholesale licence is mandatory. Premises must meet certificate of suitability requirements. A supervising pharmacist must be present. Annual import permits are required from NDA. Only NDA-registered and verified drugs are permitted entry into the supply chain. Verification committee review of proforma invoices must occur before drug dispatch.
The integrated supply model
Companies that supply both medical devices and pharmaceutical products offer a simplified procurement channel for hospitals and clinics. This integration reduces administrative complexity, improves traceability, and strengthens the overall supply chain — particularly valuable in settings where procurement capacity is limited.
Looking forward
Adoption of Electronic Logistics Information Systems, improved cold chain infrastructure, and public-private partnerships will be key to modernising Uganda's pharmaceutical supply chain.